Refine by
Gut Microbiome Suppliers Near Tonga
32 companies found
based inMonmouth Junction, NEW JERSEY (USA)
Notitia ('NO-TEE-SHA') means 'data' in Latin. We are a next-generation microbiome company that unlocks the gut microbiome's data to develop innovative products and therapies for patients and the general public. Our mission is to promote health by ...
This investigational drug is designed to treat diseases by replenishing the missing or extinct Foundation Guild™ bacteria in a patient's gut ...
based inOttawa, ONTARIO (CANADA)
Our success is based on our strong relationship with our valued customers, our innovative environment and our passion for quality. DNA Genotek, a subsidiary of OraSure Technologies, Inc., develops products that optimize ease of collection and ...
PERFORMAbiome•GUT is a simple all-in-one system for easy collection and stabilization of DNA for animal microbiome profile ...
based inGlasgow, UNITED KINGDOM
We’re a leading microbiome therapeutics company. We have established proprietary MHRA licensed manufacturing capabilities and a supply chain model that enables us to leverage a pipeline of internal and partnered programmes around our lead asset, ...
The gut-liver-brain axis describes the interplay of immune, metabolic and neuroendocrine biology that is increasingly being recognised as a potential therapeutic ...
based inPort Chester, NEW YORK (USA)
For over 25 years, OMNi-BiOTiC® has been a leading professional probiotic brand in Europe. In 2019, our dedicated team based in New York introduced Omni-Biotic to the United States. Our targeted Omni-Biotic blends developed for stress, immunity, ...
This 3-month OMNi-BiOTiC® probiotic program is designed to reset the gut microbiome and support overall wellness. Based on over 30 years of gut microbiome research and 100+ ...
based inBrisbane City, AUSTRALIA
Microba’s precise microbiome analysis is built on the expertise of our innovative team at the leading edge of microbiome science. Our approach to microbiome analysis is enabling new discoveries and advancing the understanding of the microbiome in ...
Measure the impact of treatments on the microbiome; The microbiome’s central role in health makes it an important system to examine in the development and testing of new therapies. With highly accurate metagenomic analysis of the microbiome ...
based inCopenhagen, DENMARK
Cmbio specializes in advancements in microbiome science and multi-omics research, primarily focused on human, animal, and planetary health. With a team of over 100 experts in microbiology, bioinformatics, metabolomics, molecular biology, and data ...
The gut microbiome is central to digestive health and metabolic processes, influencing conditions such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and metabolic disorders like obesity and ...
based inOslo, NORWAY
Bio-Me is Setting the Standard for Routine Microbiome Analysis. Gut microbiome research has become essential to almost every medical research field. Next-generation sequencing (NGS) technologies have been crucial in enabling a breakthrough in our ...
Our latest ready-to-use microbiome analysis solution. It consists of close to 100 unique assays for specific bacterial and fungal targets, including two controls. Targets were selected after extensive literature and database ...
based inHeslington, UNITED KINGDOM
OptiBiotix Health Plc. is a life sciences company operating in one of the most progressive areas of biotechnological research. Developing technologies that modulate the human microbiome – the collective genome of the microbes in the body – ...
Transforming the way weight loss is traditionally approached, SlimBiome® offers a healthy, hunger-free weight management system that is backed by strong scientific principles rather than simply relying on willpower. An award winning functional ...
based inSaint Augustine, FLORIDA (USA)
Microbiome Labs is an all-inclusive resource center designed to address the needs of physicians and health care practitioners. The origin story of Microbiome Labs is a classic tale of forging new frontiers, complete with discovery, adversity, and a ...
SereneSkin™ is a unique blend of four spore-forming Bacillus probiotic strains with added vitamin K2 for overall skin microbiome and gut-skin axis support. ...
based inParis, FRANCE
Enterome is pioneering the discovery and development of novel pharmaceuticals based on its unrivalled understanding of the interaction between the gut microbiome and the immune system – the Microbiome-Immunoinflammation Axis. Enterome is using this ...
OncoMimicsTM vaccines are a specific combination of bacterial peptides, derived from bacteria present in the gut microbiome, that closely mimic either overexpressed tumor-associated antigens (TAAs) or ...
based inSan Carlos, CALIFORNIA (USA)
Developing live biotherapeutics to prevent and treat diseases of high unmet medical need. We leverage our deep knowledge of the human microbiome and its regulatory and developmental functions to develop live biotherapeutic products (LBPs) and ...
Several additional risk factors for NEC, including initiation of enteral feeding, antibiotic treatment, and acid suppression treatment, are key factors influencing the development of the preterm infant gut ...
based inGermantown, MARYLAND (USA)
Based in Germantown, MD, CosmosID®’s CLIA-certified, GCP-compliant laboratory provides the microbiome field with access to standardized and validated metagenomics solutions so that industry, academia & clinicians can unlock the microbiome with ...
Through extensive R&D, the CosmosID team have established optimum read depth ranges for different samples types, using species and strain-level Bioinformatics. Whilst the optimum depth for any given sample will depend on study ...
based inBrighton, UNITED KINGDOM
Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention. We have two exciting late-stage clinical assets and a range of earlier research programmes. Our ...
Background to the NTCD-M3 Clostridioides difficile Programme. NTCD-M3 was developed by GI infection physician, Professor Dale Gerding, who is a world-leading specialist in C. difficile, with more than 400 peer-reviewed journal publications, book ...
based inBoston, MASSACHUSETTS (USA)
Like our customers and their consumers, we needed a real change in the probiotic world that would result in products with benefits we can all feel. We knew current probiotics on the market deliver unpredictable benefits for some people, while not ...
Yso4 is an exploratory program targeting the gut-brain axis for the treatment of mood disorders. Over the last 5 years, there has been increasing evidence that the gut microbiome was associated with ...
based inSeongnam-si, SOUTH KOREA
LISCure Biosciences Provides Novel Therapeutics to Patients with Refractory Diseases Using the LMT Platform. LISCure is developing the world’s first injectable immuno-oncology program using non-pathogenic microorganisms. We focus on the development ...
based inNew York, NEW YORK (USA)
NuBiyota is a microbiome therapeutics company focused on the development of novel microbiota-based drugs to restore crucial gut equilibrium. An imbalance in this crucial ecosystem is associated with infections, chronic disease and even neurological ...
based inCambridge, MASSACHUSETTS (USA)
Seres Therapeutics is a late-clinical stage biotechnology company with a strong development pipeline and rigorous scientific underpinning, working to revolutionize treatment of a wide range of diseases by modulating the function of the human ...
SER-301 is an investigational, oral, rationally-designed, fermented microbiome therapeutic for the treatment of mild-to-moderate ulcerative colitis (UC). SER-301 is a consortium of multiple bacterial strains that is manufactured by fermenting each ...
based inRoseville, MINNESOTA (USA)
Rebiotix Inc., a Ferring Company, is a clinical stage biotechnology company founded to revolutionize the treatment of debilitating diseases by harnessing the power of the human microbiome. The company is on the forefront of an exciting potential ...
based inCambridge, UNITED KINGDOM
Owlstone Medical is developing a breathalyzer for disease. With a goal to find ways to improve non-invasive diagnostics for respiratory diseases, liver diseases, cancer, digestive health and other conditions. Our mission is to save 100,000 lives and ...
based inSchlieren, SWITZERLAND
Based on our research, we believe that the common denominator underlying each intestinal microbiome is a network of interconnected, interdependent and metabolic functions that are essential for the host and the microbiome. PharmaBiome has developed ...
We take a bottom-up approach and engineer bacterial consortia based on their interactions. Our deep understanding of function drives the selection of individual strains, which are then co-cultured using our proprietary ...